Timeline
Cannabis & Wellness
Small Caps Today: Bluebird options Mexican gold project, Firering, Futura Medical, Asiamet, Kefi, Ferrexpo
Futura Medical retail offer oversubscribed, raise upsized to £200,000
Health & Bio Today: Futura Medical narrows loss, AstraZeneca, Wellnex Life, Novacyt, Renalytix, GSK, Ondine Biomedical
Futura Medical narrows loss as Haleon settlement lifts first-half revenue
Futura Medical wins EU and UK clearance for Eroxon Intense
ProBiotix supplies LPLDL strain for iProbio’s CARDIObiom+ launch
More in Healthcare
Fusion Antibodies swings to narrower loss as margins jump
The antibody discovery specialist reported 7% revenue growth and a sharp gross margin improvement for the year to March, as OptiMAL launched commercially and cash more than trebled.